Patents by Inventor Johanna Elisabeth FRASER

Johanna Elisabeth FRASER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF VIRAL INHIBITION
    Publication number: 20240016767
    Abstract: This invention relates to methods of treating or preventing viral infections caused by flaviviruses, such as dengue virus, yellow fever virus, West Nile virus or Japanese encephalitis virus or infections caused by Chikungunya virus (CHIKV). The methods involve the administration of retinoic acid analogues to subjects who have, are suspected of having a flavivirus infection or infection with CHIKV, or to those who are at risk of becoming infected with a flavivirus or becoming infected with CHIKV.
    Type: Application
    Filed: July 20, 2023
    Publication date: January 18, 2024
    Inventors: Johanna Elisabeth FRASER, David Andrew JANS, Kylie Michelle WAGSTAFF
  • Method of viral inhibition
    Patent number: 11752116
    Abstract: This invention relates to methods of treating or preventing viral infections caused by flaviviruses, such as dengue virus, yellow fever virus, West Nile virus or Japanese encephalitis virus or infections caused by Chikungunya virus (CHIKV). The methods involve the administration of retinoic acid analogues to subjects who have, are suspected of having a flavivirus infection or infection with CHIKV, or to those who are at risk of becoming infected with a flavivirus or becoming infected with CHIKV.
    Type: Grant
    Filed: April 19, 2021
    Date of Patent: September 12, 2023
    Assignee: Monash University
    Inventors: Johanna Elisabeth Fraser, David Andrew Jans, Kylie Michelle Wagstaff
  • METHOD OF VIRAL INHIBITION
    Publication number: 20220016057
    Abstract: This invention relates to methods of treating or preventing viral infections caused by flaviviruses, such as dengue virus, yellow fever virus, West Nile virus or Japanese encephalitis virus or infections caused by Chikungunya virus (CHIKV). The methods involve the administration of retinoic acid analogues to subjects who have, are suspected of having a flavivirus infection or infection with CHIKV, or to those who are at risk of becoming infected with a flavivirus or becoming infected with CHIKV.
    Type: Application
    Filed: April 19, 2021
    Publication date: January 20, 2022
    Inventors: Johanna Elisabeth FRASER, David Andrew JANS, Kylie Michelle WAGSTAFF
  • Method of viral inhibition
    Patent number: 11007160
    Abstract: This invention relates to methods of treating or preventing viral infections caused by flaviviruses, such as dengue virus, yellow fever virus, West Nile virus or Japanese encephalitis virus or infections caused by Chikungunya virus (CHIKV). The methods involve the administration of retinoic acid analogues to subjects who have, are suspected of having a flavivirus infection or infection with CHIKV, or to those who are at risk of becoming infected with a flavivirus or becoming infected with CHIKV.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: May 18, 2021
    Assignee: Monash University
    Inventors: Johanna Elisabeth Fraser, David Andrew Jans, Kylie Michelle Wagstaff
  • METHOD OF VIRAL INHIBITION
    Publication number: 20160074346
    Abstract: This invention relates to methods of treating or preventing viral infections caused by flaviviruses, such as dengue virus, yellow fever virus, West Nile virus or Japanese encephalitis virus or infections caused by Chikungunya virus (CHIKV). The methods involve the administration of retinoic acid analogues to subjects who have, are suspected of having a flavivirus infection or infection with CHIKV, or to those who are at risk of becoming infected with a flavivirus or becoming infected with CHIKV.
    Type: Application
    Filed: April 16, 2014
    Publication date: March 17, 2016
    Inventors: Johanna Elisabeth FRASER, David Andrew JANS, Kylie Michelle WAGSTAFF